Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.15M | 1.06M | 896.80K | 1.11M | 843.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.15M | 1.06M | 896.80K | 1.11M | 843.90K |
| Cost of Revenue | 609.20K | 525.40K | 437.00K | 593.50K | 508.30K |
| Gross Profit | 536.60K | 535.40K | 459.70K | 518.30K | 335.60K |
| SG&A Expenses | 2.99M | 2.46M | 2.34M | 2.66M | 2.72M |
| Depreciation & Amortization | 288.20K | 290.40K | 281.90K | 303.40K | 300.30K |
| Other Operating Expenses | -246.10K | -165.70K | -72.70K | -193.30K | -383.90K |
| Total Operating Expenses | 5.11M | 4.00M | 3.51M | 3.85M | 3.73M |
| Operating Income | -3.96M | -2.94M | -2.61M | -2.74M | -2.89M |
| Income Before Tax | -3.92M | -2.87M | -2.69M | -3.00M | -3.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.92M | -2.87M | -2.69M | -3.00M | -3.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.80K | 6.90K | 9.00K | 12.00K | 12.50K |
| Net Income | -3.91M | -2.86M | -2.68M | -2.98M | -3.09M |
| EBIT | -3.96M | -2.94M | -2.61M | -2.74M | -2.89M |
| EBITDA | -3.52M | -2.81M | -2.28M | -2.48M | -2.64M |
| EPS Basic | -1.56 | -1.80 | -2.82 | -3.49 | -4.42 |
| Normalized Basic EPS | -0.97 | -1.12 | -1.74 | -1.98 | -2.56 |
| EPS Diluted | -1.56 | -1.80 | -2.82 | -3.49 | -4.42 |
| Normalized Diluted EPS | -0.97 | -1.12 | -1.74 | -1.98 | -2.56 |
| Average Basic Shares Outstanding | 2.50M | 1.59M | 950.80K | 854.70K | 699.90K |
| Average Diluted Shares Outstanding | 2.50M | 1.59M | 950.80K | 854.70K | 699.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |